Key facts
- Notable investors include Creative Destruction Lab, University of Toronto, Government of Canada, Campus des technologies de la santé, Glen Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Paratus Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Paratus Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Paratus Medical
Developer of a clinical decision support application designed to guide healthcare professionals during critical resuscitation scenarios. The company's tool delivers rapid offline access to dosing, drug references, and patient-specific calculations, enabling frontline medical teams to make accurate, life-saving decisions in high-pressure environments.
- Sector
- Healthcare
- HQ
- Montreal, Canada
- Founded
- 2019
- Employees
- 11
- Website
- sparatusmedical.com/
- Ownership
- Privately Held (backing)
Paratus Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Paratus Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Paratus Medical in its N-PORT filings yet. We sweep new filings monthly.